Digital pharmacoepidemiology of angiotensin-converting enzyme inhibitors in Russia

Stanislav Kotlyarov, Anna Kotlyarova

Open source

DOI
10.3389/fphar.2026.1881727
Published
2026-07-23
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1881727,
  title = {Digital pharmacoepidemiology of angiotensin-converting enzyme inhibitors in Russia},
  author = {Stanislav Kotlyarov and Anna Kotlyarova},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1881727},
  url = {https://doi.org/10.3389/fphar.2026.1881727}
}

RIS

TY  - JOUR
TI  - Digital pharmacoepidemiology of angiotensin-converting enzyme inhibitors in Russia
AU  - Stanislav Kotlyarov
AU  - Anna Kotlyarova
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1881727
UR  - https://doi.org/10.3389/fphar.2026.1881727
ER  - 

APA

Kotlyarov, S., & Kotlyarova, A. (2026). Digital pharmacoepidemiology of angiotensin-converting enzyme inhibitors in Russia. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1881727

Source records